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Abstract
Background: Iodine deficiency and thyroid dysfunction during pregnancy is associated with number of adverse
outcomes that includes mental and physical disabilities creating a huge human and economic burden in later life.
Several indicators are used to assess the iodine status of a population: thyroid size by palpation and/or by
ultrasonography, urinary iodine excretion and the blood thyroid hormone profile.
Methods: This prospective study was designed to assess the iodine nutrition during the course of pregnancy with
reference to urine iodine concentration (UIC) and thyroid determinants among 425 pregnant women from Galle
district, Sri Lanka. UIC was estimated in all three trimesters and thyroid functions were assessed in first and third
trimesters.
Results: Median (inter-quartile range IQR) UIC was 170.9 (100.0–261.10) μg/L, 123.80 (73.50–189.50) μg/L and 105.95
(67.00–153.50) μg/L in the first, second and third trimesters respectively (p < 0.001). Median thyroid stimulating
hormone (TSH) level in the first trimester was 1.30 (0.80–1.80) µIU/mL. This value significantly increased (p< 0.001) to 1.
60 (1.20–2.10) µIU/mL at the 3rd trimester even though it was maintained within the reference range (0.3 – 5.2 µIU/mL). In
the assessment of thyroid gland, 67 (16.0 %) women had palpable or visible goitres and 55 (13.1 %) had a goitre that was
palpable but not visible. The median thyroid volume of the sample was 5.16 mL (4.30; 6.10 mL) as measured by ultra sound
(US) scanning. In multiple regression analysis after controlling for other independent variables (anthropometric,
demographic and biochemical parameters); initial body mass index (BMI), goitre size, thyroid volume and parity had
significant correlations with the third trimester urinary iodine levels. The thyroid volume accounted for 4.5 % of the urinary
iodine variation.
Conclusions: Even though iodine status was progressively worsening with the advancement of pregnancy and iodized salt
consumption has not met with the increasing demand for iodine, it was not reflected in the serum TSH level. Therefore, it
is worthwhile to assess the long term effects of rising TSH levels and inadequate iodine nutrition during pregnancy on the
offspring to prevent even mild iodine deficiency.
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Background
Maternal iodine deficiency and thyroid dysfunction during
pregnancy is associated with number of adverse outcomes.
During the first two trimesters of pregnancy, the foetus is
entirely dependent on the maternal thyroid hormone
supply because the foetal thyroid does not develop until
13–15weeks of gestation [1]. As the foetus progresses into
the third trimester, it develops the ability to produce its
own thyroid hormones but still dependent on maternal
iodine for hormone synthesis [2]. Thyroid hormone is re-
quired for normal neuronal migration, myelination, and
synaptic transmission and plasticity during fetal and early
postnatal life and hypothyroxinemia during these critical
periods causes irreversible brain damage with mental re-
tardation and neurologic abnormalities [3]. Further, it was
reported that elevated maternal thyroid stimulating hor-
mone (TSH) has been associated with an increased risk of
pre-term birth, placental abruption, foetal death, and im-
paired neurological development in the child [4].
Urine iodine concentration (UIC) remains the gold
standard in monitoring iodine nutrition at the population
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level [5]. Serum TSH can be used as an indicator of iodine
nutrition, because it is determined mainly by the level of
circulating thyroid hormone, which in turn reflects iodine
intake. However, in older children and adults, although
serum TSH may be slightly increased due to iodine defi-
ciency, values often remain within the normal range [3].
As a single hormone determinant, serum TSH provides
the most sensitive index to reliably detect thyroid function
abnormalities [6]. Therefore, this study was designed to
assess the iodine nutrition of pregnant women prospect-
ively during the course of the pregnancy with reference to
the urine iodine concentration and the thyroid functions.
It was also aimed at evaluating the effectiveness of salt
iodization programme in maintaining iodine nutrition
among pregnant women in Sri Lanka.
Methods
This prospective cohort study was conducted in the
Galle district in the South of Sri Lanka during the period
from July 2012 to September 2014 with approval of the
Ethics Review Committee of the Faculty of Medicine,
University of Ruhuna, Sri Lanka. The calculated sample
size was 385. A possible prevalence of 50 % iodine defi-
ciency among pregnant women was assumed and it was
further inflated by 10 % to cover up possible termination
of pregnancies and drop outs during the study period.
Altogether 425 pregnant women were enrolled in the
study. With an informed consent, pregnant women with
gestational age: ≤ 12 weeks (calculated by the date of last
menstrual period) were included in the study. Pregnant
women with previous history of thyroid and renal dis-
eases were excluded. Data collection was done by using
a pretested interviewer administered questionnaire.
An examination of the neck was done to assess the
size of the thyroid gland by palpation and by ultrasound
(US) scanning at their antenatal clinics using a portable
scanner with a high frequency linier 7.5–10 MHz trans-
ducer. The volume of the thyroid gland was calculated
from the measurements of the depth (d), the width (w),
and the length (l) of each lobe by the formula recom-
mended by World Health Organization [7]. The thyroid
volume taken was the sum of volumes of both lobes.
The volume of the isthmus was not included as the
measurement did not include the thyroid capsule (hyper
echoic to the gland tissue) or the thyroid isthmus.
Clean mid stream spot urine samples were collected
from study subjects at the study entry, at the second (at
or around 24th weeks of gestation) and at the third (at or
around 36th weeks of gestation) trimesters to iodine free,
screw capped plastic containers. Collected urine samples
were transported in cold packs to the laboratory and
stored at −80 °C until the analysis was completed. Urine
samples were analyzed in duplicate within a week of col-
lection using ammonium persulfate digestion method [7]
at the iodine contamination free laboratory. Blood samples
of 5 mL were drawn from each participant, at the study
entry and at the third trimester and serum was separated
and stored at -80 °C until analysis for thyroid profile (TSH,
free thyroxine and thyroglobulin) was done. Thyroid profile
was measured using enzyme-linked immunosorbent assay
(ELISA) kits provided by MP Biochemicals, USA. The refer-
ence values recommended by the American Thyroid associ-
ation (ATA) for TSH during pregnancy, 0.1–2.5 µIU/mL in
the first trimester and 0.3–3.0 µIU/mL in the third trimester
[8] were used for comparison.
Statistical methods
Results of laboratory analysis are presented as mean ±
standard deviation (SD) or median with inter-quartile
range (IQR). For variables exhibiting a skewed distribu-
tion, the median was used as the measure of central ten-
dency together with the IQR. Wilcoxon signed ranks
test was used to compare biochemical parameters at dif-
ferent intervals and linear regression analysis to test for
correlations between UIC with other variables. A p-value
less than 0.05 was considered as significant. Statistical
analyses were performed using the SPSS version 16
(SPSS, Chicago, IL).
Results
The mean age of the 425 pregnant women included in
the study was 28.2 years (range 16 – 44 years). However,
52 pregnant women were lost on follow up,22 had early
termination of pregnancy; 10 did not attend clinics; 14
moved from the region; 6 refused to attend phlebotomy
sessions). Therefore, only 389 and 373 urine samples
were analysed in the second trimester and the third tri-
mester respectively. Mean ± SD height and weight of the
study subjects were 154.2 ± 6.1 cm and 51.7 ± 10.1Kg re-
spectively. The mean BMI of the women at study entry
was 22.2 kg/m2 and 32.4 % of the women were classified
as undernourished (BMI <18.5 kg/m2). Further, 166
(39.1 %) women were in their first pregnancy. 301
(70.8 %) were Sinhalese and the rest (n = 124, 29.2 %)
were Muslims. Even though 322 (75.76 %) women had
completed education up to secondary level, only 104
(24.5 %) were employed and the demographic data of
the study sampleis given in Table 1.
In the assessment of thyroid gland, it was revealed that
67 (16.0 %) women had palpable or visible goitres and 55
(13.1 %) of them had a goitre that was palpable but not
visible. The median thyroid volume of the sample was
5.16 mL (IQR 4.30; 6.10 mL) as measured by US scanning.
The thyroid volume has shown a significant direct rela-
tionship with the gland size since the mean ± SD volume
among grade 0 was 5.25 ± 1.5 ml; grade 1 was 5.89 ±
1.6 ml whereas grade 2 was 8.11 ± 6.1 ml (t test 16.9, p <
0.001). Further, it was evident that mean thyroid volume
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(5.10 ± 1.9 ml) of women who were in their first preg-
nancy was significantly low (t test 14.1, p < 0.001) when
compared with that of women who were in their second
or subsequent pregnancies (mean volume of 5.61 ±
1.9 ml). Further, the younger women (age <25 years) had
significantly lower mean thyroid volume (t test 5.08, p =
0.04) when compared with older group (age > 25.1 years)
of pregnant women (5.11 ± 1.4 ml vs. 5.61 ± 2.3 ml
respectively).
The median UIC of women dropped significantly with
progression of pregnancy (p < 0.001), and the concentra-
tions varied widely at each trimester (Table 2). The median
UIC of the women in first trimester was 170.9 μg/L (IQR
100.00 – 261.10 μg/L). It was dropped to 123.80 μg/L (IQR
73.50 – 189.50 μg/L) at the second trimester (Z = 7.28; p <
0.001). A further drop of UIC at the end of 3rd trimester to
105.00 μg/L (IQR 67.00 – 153.50 μg/L) was evident with a
statistically significant reduction (Z = 4.11; p < 0.001). The
first trimester urinary iodine level has a significant positive
correlation (r = 0.124, p = 0.02) with women’s weight, but
not with any other parameters (demographic & biochem-
ical) at the study entry.
The serum TSH level of the subjects in their 1st
trimester was 1.3 µIU/mL (IQR 0.8–1.8 µIU/mL). At the
end of the 3rd trimester it was significantly increased to
1.6 µIU/mL (IQR 1.2–2.1 µIU/mL) (Z-test = 6.4, p <
0.001). When method specific reference values for
pregnancy (0.3–5.2 µIU/mL) is used to determine the
prevalence of hypothyroidism, 10 (2.4 %) and 2 (0.5 %)
pregnant women with serum TSH >5.2 µIU/mL at the
first trimester and third trimester respectively were iden-
tified. None of them had serum TSH values below the
lower limit of the reference range. As per ATA reference
values, 47 (11.2 %) subjects in the first trimester and 32
(8.7 %) at the third trimester were hypothyroid, indicat-
ing a higher prevalence. Median vales of fT4 for first and
third trimesters were 18.0 pmol/L and 15.5 pmol/L (p =
0.002) respectively. None of the subjects were found
with fT4 values below the lower limit (<6.4 pmol/L) of
the method specific reference (hypothyroid) range in
both first and third trimesters. Serum thyroglobulin level
was also determined to assess the maternal iodine nutri-
tion among pregnant women at the study entry and the
median thyroglobulin level was 5.09 μg/L. Of the sample,
47 subjects had thyroglobulin level < 3.0 μg/L.
We performed multiple regression analysis with step-
wise elimination (forward and backward) to assess the
effect of selected explanatory variables on the urinary
iodine levels at first and third trimester respectively
(Table 3). After controlling for other independent vari-
ables (anthropometry, demographic and biochemical pa-
rameters), only weight was found to have statistically
significant correlations with the first trimester urinary
iodine level. However, initial body mass index (BMI),
goitre size, thyroid volume and parity had significant
correlations with the third trimester urinary iodine
levels. Furthermore, thyroid volume accounted for 4.5 %
of the urinary iodine variation (r2 = 0.045).
Discussion
The present study shows that the iodine level of preg-
nant women in Galle, Sri Lanka was adequate at the on-
set of pregnancy where as there were only 4.3 %
pregnant women with moderate iodine deficiency (urin-
ary iodine <50.0 μg/L). However, with the progression of
pregnancy there was steady decline in maternal urinary
iodine status and increase in deficiency status and the
observed difference was highly significant (p < 0.001).
Such progressive decline in urine iodine level with the
advancement of gestational age was quite compatible
with the results of studies done in Bangladesh [9],
Congo [10], Nigeria [11] and in some other countries
too [12–14]. This reduction in UI concentration can be
attributed to the miss-match between the increased de-
mand and the supply of iodine with the advancement of
the pregnancy [15]. A recent study done in France
showed that median urine iodine level in the first tri-
mester of the pregnancy was low (116.0 μg/L) [4] and
similar finding was reported from Thailand (median UI
level of 108.0 μg/L in 1st trimester pregnant women) too
[16]. It was evident that even in iodine-sufficient
Table 1 Baseline characteristics of study participantsa
Characteristics n %
Age in years
16 – 25 138 32.6
26 – 35 242 57.0




≥ 4 24 5.6
Level of education
Primary & Secondary 100 23.7
Passed O/L 148 34.3
Passed A/L & above 177 42.0
Social class
Class – I & II 68 16.0
Class – III & IV 213 50.2
Class – V & VI 144 33.8
Thyroid size
Grade 0 354 84.1
Grade 1 55 13.1
Grade 2 12 2.8
athere were 425 participants at the study entry
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countries pregnant women may be at risk of mild deficiency;
because of the major physiological changes in thyroid func-
tion occurring during pregnancy leading to increased loss of
iodine and the need of much higher iodine supply [17].
In contrast, results of national health and nutrition
examination survey in USA showed that UI levels were
increased in the second and third trimesters when com-
pared to the first trimester [18]. This increase in iodine
status was attributed to the usage of supplements con-
taining iodine during pregnancy. However, Sri Lanka did
not prescribe supplements containing iodine during
pregnancy as a part of their antenatal management. Fur-
ther, a recent study done in India showed that mean UI
levels above normal in all trimesters, with a peak in
mid-pregnancy with no inter-trimester variation and
only a very few (2 %) had iodine deficiency [19].
An assessment of thyroid functions concurrently with
urinary iodine level would give a clear picture on maternal
iodine nutrition. Thyroid dysfunction during pregnancy
was classified from subclinical hypothyroidism (SCH) to
overt hypothyroidism (OH). The SCH was defined as hav-
ing serum TSH level in the range of 2.5–10.0 µIU/mL with
a normal fT4 concentration. The distinction of OH from
SCH was important because around 2.0–2.5 % of healthy
non pregnant women in United States were considered as
having SCH, but it would be anticipated that such per-
centages would be higher in areas of iodine insufficiency
[8]. Since the SCH is a biochemical diagnosis, the symp-
toms may be mild, non-specific and may mimic typical
symptoms in pregnancy. The increase in serum TSH level
with the advancement of pregnancy in our study was com-
patible with the findings of the study done in Bangladesh
[9]. A recent study done on pregnant women (in their
second trimester) in Iran showed that the prevalence of
hypothyroidism in pregnant woman was 13.7 % and the
prevalence of hyperthyroidism was 1.5 % [20]. Further,
Yassaee et al., [21] in 2014 reported 4.15 % prevalence of
SCH in the same country. The prevalence of
Table 2 Biochemical parameters during pregnancya
First trimester Second trimester Third trimester
n 425 389 373
Weeks (weeks) 9.5 ± 1.8 25.3 ± 1.4 36.6 ± 0.6
Urinary iodine (μg/L)
Median 170.90 123.80 105.00
25th – 75th percentiles 100.00 – 261.10 73.50 – 189.50 67.00 – 153.50
10th – 90th percentiles 68.40 – 329.70 46.00 – 250.30 49.20 – 218.80
Total range 6.30 – 491.70 5.80 – 466.70 16.20 – 505.50
n (%) <50 μg/Lb 18 (4.3) 36 (9.6) 40 (10.8)
n (%) <150 μg/Lb 159 (37.4) 168 (45.0) 232 (62.2)
n (%) >250 μg/Lb 124 (29.1) 37 (10.7) 26 (6.9)
Serum TSH (µIU/mL)
Median 1.30 1.60
25th – 75th percentiles 0.80 – 1.90 1.20 – 2.10
10th – 90th percentiles 0.50 – 2.50 0.80 – 2.98
Total range 0.40 – 16.60 0.50 – 11.60
Serum fT4 (pmol/L)
Median 18.00 15.45
25th – 75th percentiles 15.45 – 23.20 11.60 – 21.80
10th – 90th percentiles 10.60 – 28.30 10.30 – 28.30
Total range 10.30 – 42.50 10.30 – 39.90
Serum Thyroglobulin (μg/L)
Median 5.09
25th – 75th percentiles 1.97 – 7.37
10th – 90th percentiles 0.38 – 15.65
Total range 0.14 – 42.0
aUrinary iodine levels was assessed at each trimester, except for serum thyroglobulin other biochemical parameters were assessed at the study entry (first trimester) and
towards the end of third trimester
bWorld Health Organization’s criteria for assessing iodine status on population basis: for pregnant women moderate iodine deficiency <50 μg/L insufficient intake
<150 μg/L and above requirement >250 μg/L
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hypothyroidism among north Indian pregnant women
was14.3 % during the first trimester [22].
Sri Lanka was categorized as a country with satisfactory
iodine nutrition status and the coverage of adequate io-
dized salt usage was >90 % [23]. Further, Sri Lanka was
considered as having achieved all the criteria of WHO/
ICCIDD for monitoring progress towards sustainable
elimination of IDD. However, no national level studies
have been conducted to assess the iodine nutrition in
pregnant women in Sri Lanka up to 2010, when a study
revealed that the overall median urine iodine concentra-
tion among pregnant women was 113.7 μg/L indicating an
iodine deficiency in Sri Lankan pregnant women [24].
This cross sectional study showed that pregnant women
who were in the second and third trimesters had lower UI
level than first trimester pregnant women. To our know-
ledge, present study is the first prospective study done in
Sri Lanka to assess the gestational changes in iodine nutri-
tion along with the thyroid profile assessment.
In this group of pregnant women, UI level was signifi-
cantly reduced over the period of gestation and almost
three fourth of the pregnant women were iodine
deficient (<150.0 μg/L) towards the end of the preg-
nancy. However, this iodine deficiency status was appar-
ently not reflected by the serum TSH level. Even though
iodine deficiency was a significant problem in this sam-
ple, prevalence of severe iodine deficiency (<50.0 μg/L)
was very low. Results of the present study confirmed
that pregnant women in this study population were hav-
ing mild iodine deficiency with normal TSH level. Main-
taining median serum TSH level within the reference
range (increased serum TSH values remained within the
normal range) with progressive increase in iodine defi-
ciency in this study sample may be explained by this
mild iodine deficiency status and the foetuses of mothers
who are apparently euthyroid may have insufficient T4
for its normal neurodevelopment [25]. These conditions
have been found to be related to mild and subclinical
cognitive and psychomotor deficits in neonates, infants
and children [17] and it highlights the importance of
maintaining proper iodine nutrition throughout the
pregnancy to ensure optimal maternal thyroid function
for a better pregnancy outcome.
This study has some important points. The design was
suited to evaluate changes in iodine nutrition during the
course of the pregnancy because we measured the urine
iodine excretion in each trimester in the same study sub-
ject whereas many of the other studies were done in
cross- sectional manner [18, 24, 26, 27]. Pregnant
women of the study sample were not given iodine sup-
plements and it mainly explores the effectiveness of io-
dized salt, diet and water as sources of iodine during
pregnancy. The main limitations were the lack of infor-
mation concerning iodine concentrations in edible salts
utilized at each household and recruitment of pregnant
women from a health division close to the main city of
the Southern province where there may be a difference
in level of education, nutritional status and social class
compared to the general population of the country.
Therefore the results may not be generalized to the Sri
Lankan pregnant population. It would have been useful
to have a non-pregnant control group from the same
area to ascertain whether lower UI concentrations dur-
ing pregnancy could be attributed to pregnancy itself or
to different dietary choices among them.
Conclusions
In conclusion, pregnant women in Galle, Sri Lanka have
generally inadequate urinary iodine excretion during pro-
gression of the pregnancy. They should be encouraged to
either consume iodine-rich food or to take appropriate
multiple micronutrient capsules including iodine to im-
prove their iodine status during pregnancy. However, exist-
ing iodine supplement through salt iodization programme
should be continued and monitored strictly with a close sur-
veillance to maintain a satisfactory iodine status in the
Table 3 Multiple regression equation with urinary iodine levels
at each trimester as the dependent variables and selected
independent variables among study subjectsa
Variable Urinary iodine (T1) Urinary iodine (T3)
ß p-value ß p-value
Anthropometry
Weight 0.157 0.006 0.090 0.37
Height −0.033 0.56 0.032 0.60
BMI 0.005 0.96 0.167 0.005
Thyroid volume −0.031 0.60 0.117 0.03
Thyroid size −0.081 0.15 0.136 0.02
Demography
Social class 0.074 0.20 −0.010 0.87
Education level 0.019 0.73 −0.008 0.90
Parity 0.062 0.28 −0.123 0.04
Age in years −0.002 0.97 −0.009 0.89
Period of gestation −0.082 0.15 0.044 0.45
Biochemical analysis
Serum TSHb −0.066 0.25 −0.006 0.92
Serum fT4
b 0.040 0.49 −0.061 0.29
Serum thyroglobulinc −0.045 0.62 −0.069 0.51
p (model) 0.006 <0.001
r2 0.025 0.045
aAnthropometry and demographic data were collected at study entry (first
trimester) were compared with urinary iodine level of first and third trimester
bThese biochemical parameters were assessed separately first trimester data
with first trimester urinary iodine and third trimester data with third trimester
urinary iodine respectively
cSerum thyroglobulin level was measured at study entry and compared with
urinary iodine level of first and third trimester
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pregnant women. Further studies are needed to clarify the
potential impact of the women’s consistently low or exces-
sive iodine intake and benefits or adverse effects of iodine
supplementation on the health of their developing offspring.
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